These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16906425)

  • 1. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
    Cao X; Fang L; Gibbs S; Huang Y; Dai Z; Wen P; Zheng X; Sadee W; Sun D
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):495-505. PubMed ID: 16906425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.
    Xu RH; Pelicano H; Zhou Y; Carew JS; Feng L; Bhalla KN; Keating MJ; Huang P
    Cancer Res; 2005 Jan; 65(2):613-21. PubMed ID: 15695406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic preconditioning up-regulates glucose transport activity and glucose transporter (GLUT1 and GLUT3) gene expression after acute anoxic exposure in the cultured rat hippocampal neurons and astrocytes.
    Yu S; Zhao T; Guo M; Fang H; Ma J; Ding A; Wang F; Chan P; Fan M
    Brain Res; 2008 May; 1211():22-9. PubMed ID: 18474279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
    Ganapathy V; Thangaraju M; Prasad PD
    Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of transport and phosphorylation of glucose in cancer cells.
    Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Moreno-Sánchez R
    J Cell Physiol; 2009 Dec; 221(3):552-9. PubMed ID: 19681047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
    Hsieh IS; Yang RS; Fu WM
    PLoS One; 2014; 9(10):e109550. PubMed ID: 25310823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
    Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
    Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
    Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
    J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.
    Tomida A; Tsuruo T
    Anticancer Drug Des; 1999 Apr; 14(2):169-77. PubMed ID: 10405643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
    Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
    Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
    Meneses AM; Medina RA; Kato S; Pinto M; Jaque MP; Lizama I; García Mde L; Nualart F; Owen GI
    J Cell Physiol; 2008 Jan; 214(1):110-6. PubMed ID: 17559076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
    Koukourakis MI; Giatromanolaki A; Harris AL; Sivridis E
    Cancer Res; 2006 Jan; 66(2):632-7. PubMed ID: 16423989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypoxia on glucose transport in primary equine chondrocytes in vitro and evidence of reduced GLUT1 gene expression in pathologic cartilage in vivo.
    Peansukmanee S; Vaughan-Thomas A; Carter SD; Clegg PD; Taylor S; Redmond C; Mobasheri A
    J Orthop Res; 2009 Apr; 27(4):529-35. PubMed ID: 18973239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs.
    Onozuka H; Tsuchihara K; Esumi H
    Cancer Sci; 2011 May; 102(5):975-82. PubMed ID: 21255190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and function of glucose transporter 1 in human mesangial cells.
    Li Y; Liu Z; Liu D; Zhang J; Chen Z; Li L
    Chin Med J (Engl); 2001 Aug; 114(8):824-8. PubMed ID: 11780359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells.
    Kominsky DJ; Klawitter J; Brown JL; Boros LG; Melo JV; Eckhardt SG; Serkova NJ
    Clin Cancer Res; 2009 May; 15(10):3442-50. PubMed ID: 19401345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
    Wang YD; Li SJ; Liao JX
    Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.